Michael Tung | Corporate Strategy/Investor Relations |
Enrique Conterno | Chief Executive Officer |
Mark Eisner | Chief Medical Officer |
Juan Graham | Chief Financial Officer |
Thane Wettig | Chief Commercial Officer |
Chris Chung | Senior Vice President of China Operations |
Michael Yee | Jefferies |
Andy Hsieh | William Blair |
Yaron Werber | Cowen |
Annabel Samimy | Stifel |
Ladies and gentlemen, thank you for standing by and welcome to the FibroGen's First Quarter 2022 Earnings Conference Call. At this time all participants' lines are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your first speaker for today, Michael Tung.